These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3713721)

  • 1. Toxicological review of busulfan (Myleran).
    Bishop JB; Wassom JS
    Mutat Res; 1986 Jul; 168(1):15-45. PubMed ID: 3713721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of busulfan on murine spermatogenesis: cytotoxicity, sterility, sperm abnormalities, and dominant lethal mutations.
    Bucci LR; Meistrich ML
    Mutat Res; 1987 Feb; 176(2):259-68. PubMed ID: 3807936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treosulphan, myleran and butadiene: similarities and differences.
    Ashby J
    Mutat Res; 1993 Jul; 300(2):77-8. PubMed ID: 7685496
    [No Abstract]   [Full Text] [Related]  

  • 4. Mutagenicity, carcinogenicity and teratogenicity of beryllium.
    Léonard A; Lauwerys R
    Mutat Res; 1987 Jul; 186(1):35-42. PubMed ID: 3600684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Busulfan administration produces sublethal effects on somatic tissues and inhibits gametogenesis in Senegalese sole juveniles.
    Pacchiarini T; Olague E; Sarasquete C; Cabrita E
    Histol Histopathol; 2014 May; 29(5):619-28. PubMed ID: 24371034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenicity, carcinogenicity and teratogenicity of antimony compounds.
    Léonard A; Gerber GB
    Mutat Res; 1996 Oct; 366(1):1-8. PubMed ID: 8921983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Sat2 expression is associated with busulfan-induced testicular Sertoli cell injury.
    Xian Y; Wu M; Liu Y; Hao J; Wu Y; Liao X; Li G
    Toxicol In Vitro; 2017 Sep; 43():47-57. PubMed ID: 28578006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel drug interaction between busulfan and blinatumomab.
    Sweiss K; Quigley JG; Oh A; Lee J; Ye R; Rondelli D; Patel P
    J Oncol Pharm Pract; 2019 Jan; 25(1):226-228. PubMed ID: 28857712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplacental transmission of busulfan (myleran) in a mother with leukemia. Production of fetal malformation and cytomegaly.
    DIAMOND I; ANDERSON MM; McCREADIE SR
    Pediatrics; 1960 Jan; 25():85-90. PubMed ID: 13816523
    [No Abstract]   [Full Text] [Related]  

  • 10. Results of toxicological studies on praziquantel.
    Frohberg H
    Arzneimittelforschung; 1984; 34(9B):1137-44. PubMed ID: 6542381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenicity, carcinogenicity and teratogenicity of zinc.
    Léonard A; Gerber GB; Léonard F
    Mutat Res; 1986 Nov; 168(3):343-53. PubMed ID: 3540646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teratogenicity of myleran against musculoskeletal tissues in the rat.
    Weingarten PL; Ream JR; Pappas AM
    Clin Orthop Relat Res; 1971; 75():236-47. PubMed ID: 5102953
    [No Abstract]   [Full Text] [Related]  

  • 13. Protective effect of amifostine on busulfan induced DNA damage in human hepatoma cells.
    Ghassemi-Barghi N; Etebari M; Jafarian-Dehkordi A
    Toxicol Mech Methods; 2017 Jan; 27(1):52-57. PubMed ID: 27771991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte colony-stimulating factor (G-CSF) promotes spermatogenic regeneration from surviving spermatogonia after high-dose alkylating chemotherapy.
    Kotzur T; Benavides-Garcia R; Mecklenburg J; Sanchez JR; Reilly M; Hermann BP
    Reprod Biol Endocrinol; 2017 Jan; 15(1):7. PubMed ID: 28077131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop.
    Kirkland D; Pfuhler S; Tweats D; Aardema M; Corvi R; Darroudi F; Elhajouji A; Glatt H; Hastwell P; Hayashi M; Kasper P; Kirchner S; Lynch A; Marzin D; Maurici D; Meunier JR; Müller L; Nohynek G; Parry J; Parry E; Thybaud V; Tice R; van Benthem J; Vanparys P; White P
    Mutat Res; 2007 Mar; 628(1):31-55. PubMed ID: 17293159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenicity, carcinogenicity and teratogenicity of thallium compounds.
    Léonard A; Gerber GB
    Mutat Res; 1997 Aug; 387(1):47-53. PubMed ID: 9254892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenicity, carcinogenicity and teratogenicity of aluminium.
    Léonard A; Gerber GB
    Mutat Res; 1988 Nov; 196(3):247-57. PubMed ID: 3059176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutagenicity, carcinogenicity and teratogenicity of procarbazine.
    Lee IP; Dixon RL
    Mutat Res; 1978; 55(1):1-14. PubMed ID: 105288
    [No Abstract]   [Full Text] [Related]  

  • 19. 1,4-Butanediol dimethanesulfonate (Myleran).
    Rep Carcinog; 2004; 11():III39-40. PubMed ID: 21089816
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytotoxicity of treosulfan and busulfan on pediatric tumor cell lines.
    Lanvers-Kaminsky C; Bremer A; Dirksen U; Jürgens H; Boos J
    Anticancer Drugs; 2006 Jul; 17(6):657-62. PubMed ID: 16917211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.